FDA-approved drugs for multiple sclerosis have no efficacy or disability data in non-Caucasian patients

Published 2019 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
FDA-approved drugs for multiple sclerosis have no efficacy or disability data in non-Caucasian patients
Authors
Keywords
-
Journal
CNS SPECTRUMS
Volume -, Issue -, Pages 1-2
Publisher
Cambridge University Press (CUP)
Online
2019-01-03
DOI
10.1017/s1092852918001517
References
View 5 related references

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.